GL1X · GenesisL1 explorer

MolNFT v1 · #92684 · protein

Design of peptide inhibitors of phospholipase A2: crystal structure of phospholipase A2 complexed with a designed tetrapeptide val - ilu- ala - lys at 2.7 a resolution

4GFY · Phospholipase A2 vrv-pl-viiia: “Design of peptide inhibitors of phospholipase A2: crystal structure of phospholipase A2 complexed with a…”. X-ray diffraction, 1 ligand (SO4), 1 pocket (best druggability 0.30). MolNFT v1 #92684 on…

PDB
4GFY
Type
protein
Length
125 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phospholipase A2 vrv-pl-viiia; Viak
EC
3.1.1.4
UniProt
D0VX11
Ligands
SO4
Pockets
1 · best druggability 0.30

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 7% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhospholipase A2 vrv-pl-viiia (EC 3.1.1.4)protein12148% helix, 7% strandD0VX11
BViakprotein40% helix, 0% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1530.300.7617empty

Interfaces

1 interface between chains.

  • A–B · 429 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 disulfide (disulfide).

Compared structures

  • 4GFY · Design of peptide inhibitors of phospholipase A2: crystal Structure of phospholipase A2… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.